To maintain favorable conditions in the brain, the blood-brain barrier limits mass transfer across brain tissue. However, it also restricts the systemic delivery of compounds to treat neurological disorders. Several treatment alternatives to bypass the BBB and infuse pharmaceuticals at high concentrations are in development.
Would you like to access this CEP Article?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.